Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q3 EPS

Go back to Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q3 EPS
(NASDAQ: CRVS) Delayed: 15.40 +0.57 (3.84%)
Previous Close $14.83    52 Week High $17.77 
Open $15.20    52 Week Low $9.63 
Day High $15.72    P/E N/A 
Day Low $14.94    EPS $0.00 
Volume 845,627